Menu
Search for
Home
News
Entertainment
Business
Sports
Games
Technology
Health
Alzeheimer
Health
Admin
November 14, 2024
0
4
Europe is changing its assessment and giving limited approval to lecanemab, a controversial Alzheimer’s disease drug.
Back to top button
Close
Search for